ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

Clinical trial NCT05077267 · COMPLETED

Trial details

NCT number: NCT05077267
Sponsor: Bavarian Nordic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Disease

Start date: 2021-08-19
Primary completion: 2022-02-02
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.